unknown

Immunotherapy Using a Novel Agonistic Anti-IL-2 Antibody Combined with Epigenetic Modulation Limits Tumor Immune Escape and Controls Tumor Growth

Authors
Publication date
1 January 2016
Publisher
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      ZORA

      redirect
      oaioai:www.zora.uzh.ch:134080
      Last time updated on 26/02/2017